MESTINON-SR
Identification of Mestinon-Sr
| No description |
Google image searchProduct monograph
Active ingredient
pyridostigmine bromide, 180 MG
DIN: 00869953
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 04-JUL-2019
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07A — PARASYMPATHOMIMETICS (ATC, ATC/DDD)
- N07AA — Anticholinesterases (ATC, ATC/DDD)
- N07AA02 — PYRIDOSTIGMINE (ATC/DDD)
Reference brand drug: Mestinon
